Embria Launches EpiCor Internationally

CEDAR RAPIDS, Iowa—Embria Health Sciences launched its EpiCor™ immunogen ingredient into the European and Brazilian markets at trade shows in May. Embria exhibited at VitaFoods in Geneva, Switzerland, and will work with its E.U. rep, Livingstone, Scott (Healthcare) & Co. Ltd., to supply the ingredient in Europe.The company also showed the ingredient at two pharma conferences in Brazil, where Embria’s South American distributor, Galena Química e Farmacecutical Ltd., will support new customers.

“We are pleased that EpiCor’s success at these prestigious international conferences has paralleled the immense interest it has received within the United States,” said Paul Faganel, president of Embria (www.embriahealth.com). “As part of Embria’s overall international growth strategy, we will continue to bring EpiCor into trade venues worldwide.”